Why Smart Eye Surgeons Still Make Bad Growth Decisions - Takeaway - MDSpire
Commentary & Perspectives

Why Smart Eye Surgeons Still Make Bad Growth Decisions

You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey

Share

  • 1

    Surgeons excel in decision-making with precise diagnostics.

  • 2

    Growth strategies often rely on misleading data.

  • 3

    Fragmented metrics hinder financial decisions.

  • 4

    An end-to-end growth scorecard improves visibility.

  • 5

    Connect input metrics to meaningful output metrics.

Original Source(s)

Why Smart Eye Surgeons Still Make Bad Growth Decisions

  • by Rod Solar

  • April 30, 2026

Related Content

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

  • April 30, 2026

  • 3 min
The New Era of Postoperative Inflammation Management

What surgeons need to know about managing post-cataract inflammation

Optogenetic RP Therapy Gains RMAT

Ray Therapeutics secures FDA RMAT designation for its optogenetic retinitis pigmentosa therapy

  • April 29, 2026

  • 2 min